A Post Marketing Surveillance to Evaluate the Safety of Desidustat for the Treatment of Anemia in Subjects With Chronic Kidney Disease (CKD).(Real World Evidence Study)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1004 participants.
Also called NCT05515367
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 1,004 participants
- Sponsor
- Registry
-
NCT05515367
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- India
- Registry status
- Recruiting
Technical summary
Registry record NCT05515367. Allocation not applicable; no masking; primary purpose treatment. Start 2023-04-20 (actual); primary completion 2025-06-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Post Marketing Surveillance to Evaluate the Safety of Desidustat for the Treatment of Anemia in Subjects With Chronic Kidney Disease (CKD).(Real World Evidence Study)
- Condition
- Chronic Kidney Diseases
- Condition
- Anemia of Chronic Kidney Disease
- Intervention (Drug)
- Desidustat
- Lead sponsor
- Zydus Lifesciences Limited
Record details
- Record id
cardio:ct-nct05515367- Content hash
65e2ca01da640ec20a2550110c6c49baba6c87ff3ceefa0e9778ea16e548f3a4